AMAZE™ Asthma Implementation QI Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Phase I Double-blind, Placebo-controlled Study of AZD7442
- Status
- COMPLETED
- Phase
- PHASE1
US PRECISION Implementation Study
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate the Effects of AZD3427 in Patients With Heart Failure
- Status
- WITHDRAWN
- Phase
- PHASE1
LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)
- Status
- COMPLETED
- Phase
- N/A
D9319C00001- 1L OC Mono Global RCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Non Interventional Pilot Study on Machine Learning for ILD Detection Based on the Patient Data From Digital Devices in Unresectable Stage III Non-Small Cell Lung Cancer Patients Receiving Durvalumab
- Status
- COMPLETED
- Phase
- N/A
Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas
- Status
- RECRUITING
- Phase
- PHASE2
Kinetics of Nasal Cytokine Responses to Mechanical Stimulation
- Status
- COMPLETED
- Phase
- NA
Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222
- Status
- TERMINATED
- Phase
- N/A
Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Dapagliflozin on Volume Vascular Outcomes.
- Status
- COMPLETED
- Phase
- PHASE4
Managing Asthma Patients With AMAZE™: A Novel Disease Management Platform
- Status
- COMPLETED
- Phase
- NA
Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Forxiga HF General Drug Use-Results Study
- Status
- COMPLETED
- Phase
- N/A
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
- Status
- RECRUITING
- Phase
- PHASE3
Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Bioequivalence of Fixed Dose Combination of Dapagliflozin/Metformin XR Relative to Co-administration of the Individual Components in Healthy Chinese Subjects.
- Status
- COMPLETED
- Phase
- PHASE1